Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Xenoport (XNPT)

Xenoport (XNPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xenoport 3410 CENTRAL EXPRESSWAY SANTA CLARA CA 95051

www.xenoport.com P: 408-616-7200

Description:

XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of existing drugs.

Key Statistics

Overview:

Market Capitalization, $K 447,590
Shares Outstanding, K 63,520
Annual Sales, $ 41,160 K
Annual Net Income, $ -82,310 K
Last Quarter Sales, $ 14,120 K
Last Quarter Net Income, $ -14,560 K
60-Month Beta 1.94
% of Insider Shareholders 5.21%
% of Institutional Shareholders 89.88%

Growth:

1-Year Return 11.87%
3-Year Return 22.74%
5-Year Return -5.48%
5-Year Revenue Growth 1,329.17%
5-Year Earnings Growth -48.21%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.23 on 05/05/16
Latest Earnings Date 08/03/16
Earnings Per Share ttm -1.21
EPS Growth vs. Prev Qtr -9.52%
EPS Growth vs. Prev Year 30.30%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

XNPT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -276.16%
Return-on-Assets % -44.68%
Profit Margin % -199.98%
Debt/Equity 5.51
Price/Sales 10.87
Price/Cash Flow N/A
Price/Book 56.92
Book Value/Share 0.12
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar